T/CCCMHPIE 6.001-2025 Active Group standards

T/CCCMHPIE 6.001-2025 Guidelines for Sustainable International Supply Chains in the Pharmaceutical Industry

Publish Date: 2025-07-08 Implement Date: 2025-07-08 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CCCMHPIE 6.001-2025

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Drugs

Publish Date: 2025-07-08

Implement Date: 2025-07-08

Scope

Scope: The core modules, indicator requirements, implementation requirements, implementation and supervision, and application of the guidelines for the sustainable development of the international supply chain in the pharmaceutical industry, covering environmental (E), social (S), governance (G), and the indicator framework of international quality management standards (GXP, WHO-GMP/WHO-GDP/ICH Q10). It is applicable to global pharmaceutical companies (covering health products such as drugs (including raw drugs and biological products), medical devices, etc.), drug R&D institutions, and pharmaceutical supply chain distribution service providers (including logistics, CRO/CMO, etc.) engaged in sustainable development management and information disclosure. Other relevant organizations may refer to and implement it accordingly; Main technical content: This standard systematically enhances the sustainability and resilience of the pharmaceutical supply chain through modular indicator design (environment/social/governance/GXP), mandatory application of digital tools (blockchain/AI), and cross-border compliance connectivity (EU carbon tariffs/WHO pre-certification).